Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Cancer Genetics' UroGenRA-Kidney Array


Cancer Genetics, a Rutherford, NJ-based provider of oncology-focused molecular testing services, recently introduced UroGenRA-Kidney, a microarray intended for kidney cancer diagnosis and subtyping.

According to the company, the test is being offered in compliance with the US Clinical Laboratory Improvement Amendment and the approval of the New York State Department of Health. CGI said that the test will be offered to clients as part of its Kidney Complete Program, a suite of tests for kidney cancer.

It claims that UroGenRA-Kidney can be used to subtype kidney cancer tissue samples among three malignant renal cell carcinoma subtypes – clear cell, papillary, and chromophobe, as well as a benign form of renal cancer, oncocytoma. The company additionally claims that the data generated by the array can be used to select the appropriate therapy based on the kidney cancer subtype.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.